Phase 3 Perioperative Nivolumab in M0 RCC  (PROSPER RCC, ECOG –ACRIN 8143) A UROLOGIST’S PERSPECTIVE

Phase 3 Perioperative Nivolumab in M0 RCC (PROSPER RCC, ECOG –ACRIN 8143) A UROLOGIST’S PERSPECTIVE

kidneycancer

3 years
966 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Mohamad E. Allaf, MD, Associate Professor of Urology, Oncology, & BME MEA Endowed Director, Minimally Invasive Surgery
Johns Hopkins Medicine presents Phase 3 Perioperative Nivolumab in M0 RCC (PROSPER RCC, ECOG ACRIN 8143) A UROLOGISTS PERSPECTIVE at the 2016 annual International Kidney Cancer Symposium.
Up Next Autoplay